Skip to main navigation Skip to search Skip to main content

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

  • The FUTURE II Study Group

    Research output: Contribution to journalArticleScientificpeer-review

    575 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1861-1868
    JournalThe Lancet
    Volume369
    Publication statusPublished - 2007
    Publication typeA1 Journal article-refereed

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this